P39748
Gene name |
FEN1 |
Protein name |
Flap endonuclease 1 |
Names |
FEN-1, DNase IV, Flap structure-specific endonuclease 1, Maturation factor 1, MF1, hFEN-1 |
Species |
Homo sapiens (Human) |
KEGG Pathway |
hsa:2237 |
EC number |
|
Protein Class |
|

Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure

Activated structure

18 structures for P39748
Entry ID | Method | Resolution | Chain | Position | Source |
---|---|---|---|---|---|
1U7B | X-ray | 188 A | B | 331-350 | PDB |
1UL1 | X-ray | 290 A | X/Y/Z | 2-380 | PDB |
3Q8K | X-ray | 220 A | A | 2-336 | PDB |
3Q8L | X-ray | 232 A | A | 2-336 | PDB |
3Q8M | X-ray | 260 A | A/B | 2-336 | PDB |
3UVU | X-ray | 238 A | B | 352-370 | PDB |
5E0V | X-ray | 207 A | C/D | 335-350 | PDB |
5FV7 | X-ray | 284 A | A/B | 1-336 | PDB |
5K97 | X-ray | 210 A | A | 2-336 | PDB |
5KSE | X-ray | 210 A | A | 2-336 | PDB |
5UM9 | X-ray | 281 A | A | 2-336 | PDB |
5ZOD | X-ray | 190 A | A | 1-333 | PDB |
5ZOE | X-ray | 195 A | A | 1-333 | PDB |
5ZOF | X-ray | 225 A | A | 1-333 | PDB |
5ZOG | X-ray | 230 A | A | 1-333 | PDB |
6TNZ | EM | 405 A | H | 1-380 | PDB |
7QO1 | EM | 440 A | Y | 1-380 | PDB |
AF-P39748-F1 | Predicted | AlphaFoldDB |
270 variants for P39748
Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
---|---|---|---|---|---|
CA6038609 rs761359771 |
3 | I>V | No |
ClinGen ExAC TOPMed gnomAD |
|
CA6038610 rs771890165 |
4 | Q>H | No |
ClinGen ExAC gnomAD |
|
CA380865869 rs1285693421 |
4 | Q>R | No |
ClinGen TOPMed |
|
rs1442954685 CA380865905 |
7 | A>T | No |
ClinGen gnomAD |
|
rs1371412552 CA380865923 |
8 | K>Q | No |
ClinGen TOPMed gnomAD |
|
CA6038612 rs760566909 |
10 | I>T | No |
ClinGen ExAC gnomAD |
|
CA380866011 rs1342986873 |
14 | A>D | No |
ClinGen Ensembl |
|
rs1342986873 CA380866016 |
14 | A>V | No |
ClinGen Ensembl |
|
CA6038613 rs766377130 |
16 | S>R | No |
ClinGen ExAC gnomAD |
|
CA380866105 rs1208658926 |
19 | R>Q | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen NCI-TCGA gnomAD |
CA6038614 rs753721269 |
19 | R>W | No |
ClinGen ExAC TOPMed gnomAD |
|
rs904014727 CA222947928 |
20 | E>K | No |
ClinGen TOPMed gnomAD |
|
CA380866167 rs1437939126 |
23 | I>S | No |
ClinGen gnomAD |
|
rs1300125593 CA380866185 |
24 | K>R | No |
ClinGen gnomAD |
|
CA380866182 rs1300125593 |
24 | K>T | No |
ClinGen gnomAD |
|
CA6038615 rs759600121 |
25 | S>N | No |
ClinGen ExAC gnomAD |
|
rs765213906 CA6038616 |
26 | Y>C | No |
ClinGen ExAC gnomAD |
|
rs1379328024 CA380866248 |
28 | G>D | No |
ClinGen TOPMed |
|
rs752884600 CA6038618 |
28 | G>S | No |
ClinGen ExAC gnomAD |
|
CA6038620 rs764353660 |
29 | R>C | No |
ClinGen ExAC gnomAD |
|
CA6038621 rs751874785 |
29 | R>H | No |
ClinGen ExAC TOPMed gnomAD |
|
rs751874785 CA380866264 |
29 | R>L | No |
ClinGen ExAC TOPMed gnomAD |
|
rs1032766776 CA222947967 |
33 | I>V | No |
ClinGen TOPMed |
|
rs899549369 CA222947968 |
35 | A>V | No |
ClinGen TOPMed gnomAD |
|
rs781676618 CA6038623 |
38 | S>N | No |
ClinGen ExAC gnomAD |
|
rs781676618 CA380866357 |
38 | S>T | No |
ClinGen ExAC gnomAD |
|
CA6038624 rs746376478 |
41 | Q>H | No |
ClinGen ExAC TOPMed gnomAD |
|
rs756703191 CA6038625 |
47 | R>C | No |
ClinGen ExAC TOPMed gnomAD |
|
rs140458864 CA6038626 |
47 | R>H | No |
ClinGen 1000Genomes ESP ExAC TOPMed gnomAD |
|
rs140458864 CA6038627 |
47 | R>L | No |
ClinGen 1000Genomes ESP ExAC TOPMed gnomAD |
|
CA6038628 rs771800022 |
48 | Q>* | No |
ClinGen ExAC gnomAD |
|
rs773029413 CA6038629 |
48 | Q>P | No |
ClinGen ExAC gnomAD |
|
rs746730684 CA6038630 |
49 | G>A | No |
ClinGen ExAC gnomAD |
|
rs1262747985 CA380866431 |
50 | G>E | No |
ClinGen TOPMed |
|
CA6038632 rs776543195 |
50 | G>R | No |
ClinGen ExAC gnomAD |
|
CA6038634 rs765263498 |
54 | Q>K | No |
ClinGen ExAC gnomAD |
|
rs1336211233 CA380866467 |
55 | N>K | No |
ClinGen gnomAD |
|
rs1213942198 CA380866470 |
56 | E>* | No |
ClinGen gnomAD |
|
rs775415268 CA6038635 |
59 | E>K | No |
ClinGen ExAC gnomAD |
|
CA380866497 TCGA novel rs1591146151 |
60 | T>P | Variant assessed as Somatic; impact. [NCI-TCGA] | No |
NCI-TCGA ClinGen Ensembl |
CA380866551 rs1244378964 |
64 | L>M | No |
ClinGen gnomAD |
|
rs373582072 CA222948035 |
65 | M>V | No |
ClinGen Ensembl |
|
rs374732129 CA6038638 |
67 | M>I | No |
ClinGen ESP ExAC gnomAD |
|
rs764263966 CA6038637 |
67 | M>V | No |
ClinGen ExAC TOPMed gnomAD |
|
rs1264740445 CA380866633 |
69 | Y>C | No |
ClinGen TOPMed gnomAD |
|
CA6038639 rs202006260 |
70 | R>C | No |
ClinGen 1000Genomes ExAC TOPMed gnomAD |
|
rs767759900 CA380866650 |
70 | R>L | No |
ClinGen ExAC gnomAD |
|
rs767759900 CA6038640 |
70 | R>P | No |
ClinGen ExAC gnomAD |
|
CA6038642 rs756555908 |
72 | I>T | No |
ClinGen ExAC gnomAD |
|
rs145709748 COSM3809763 CA6038643 |
73 | R>C | Variant assessed as Somatic; impact. breast [NCI-TCGA, Cosmic] | No |
ClinGen cosmic curated 1000Genomes ExAC NCI-TCGA gnomAD |
rs145287449 CA6038644 |
73 | R>H | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
rs1429943372 CA380866695 |
74 | M>V | No |
ClinGen TOPMed gnomAD |
|
TCGA novel | 76 | E>K | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
rs770679611 CA380866840 |
82 | V>L | No |
ClinGen ExAC TOPMed gnomAD |
|
CA6038648 rs770679611 |
82 | V>M | No |
ClinGen ExAC TOPMed gnomAD |
|
rs1272194166 CA380866857 |
83 | Y>F | No |
ClinGen gnomAD |
|
rs1173072900 CA380866879 |
84 | V>A | No |
ClinGen gnomAD |
|
rs1292756975 CA380866867 |
84 | V>I | No |
ClinGen TOPMed |
|
CA380866913 rs1208499576 |
86 | D>E | No |
ClinGen gnomAD |
|
CA6038651 rs769573710 |
87 | G>C | No |
ClinGen ExAC gnomAD |
|
rs1447886863 CA380866920 |
87 | G>D | No |
ClinGen gnomAD |
|
rs1351558940 CA380866961 |
90 | P>S | No |
ClinGen TOPMed |
|
rs1424298787 CA380867047 |
96 | E>D | No |
ClinGen gnomAD |
|
rs774473787 CA6038655 |
98 | A>V | No |
ClinGen ExAC gnomAD |
|
CA380867085 rs1417486527 |
100 | R>C | No |
ClinGen gnomAD |
|
rs1412724264 CA380867100 |
101 | S>T | No |
ClinGen gnomAD |
|
CA6038656 rs762018999 |
103 | R>Q | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen ExAC NCI-TCGA TOPMed gnomAD |
CA380867123 rs1464197025 |
103 | R>W | No |
ClinGen TOPMed |
|
rs750703675 CA6038658 |
104 | R>Q | No |
ClinGen ExAC TOPMed gnomAD |
|
rs767828296 CA6038657 |
104 | R>W | No |
ClinGen ExAC TOPMed gnomAD |
|
CA6038660 rs766728314 |
105 | A>S | No |
ClinGen ExAC TOPMed gnomAD |
|
rs1414916308 CA380867147 |
105 | A>V | No |
ClinGen gnomAD |
|
CA6038661 rs754406395 |
107 | A>S | No |
ClinGen ExAC TOPMed |
|
rs777413094 CA6038663 |
108 | E>A | No |
ClinGen ExAC gnomAD |
|
rs371381466 CA6038664 |
113 | Q>* | No |
ClinGen ESP ExAC gnomAD |
|
CA222948262 rs945654836 |
114 | A>S | No |
ClinGen TOPMed |
|
rs780924065 CA6038666 |
115 | Q>H | No |
ClinGen ExAC TOPMed gnomAD |
|
CA6038665 rs756841522 |
115 | Q>R | No |
ClinGen ExAC gnomAD |
|
CA380867286 rs1204886974 |
116 | A>V | No |
ClinGen gnomAD |
|
rs1284567207 CA380867288 |
117 | A>P | No |
ClinGen TOPMed gnomAD |
|
rs1284567207 CA380867289 |
117 | A>S | No |
ClinGen TOPMed gnomAD |
|
CA6038670 rs374555458 |
120 | E>K | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
CA380867321 rs1310094151 |
122 | E>Q | No |
ClinGen TOPMed |
|
CA380867328 rs1300262181 |
123 | V>M | No |
ClinGen TOPMed |
|
rs542212412 CA6038673 |
129 | R>Q | No |
ClinGen ExAC gnomAD |
|
rs774384229 CA6038672 |
129 | R>W | No |
ClinGen ExAC gnomAD |
|
CA380867375 rs1469471981 |
130 | L>M | No |
ClinGen gnomAD |
|
rs760889294 CA6038676 |
131 | V>G | No |
ClinGen ExAC gnomAD |
|
rs773486731 CA6038675 |
131 | V>L | No |
ClinGen ExAC TOPMed gnomAD |
|
rs1184364525 CA380867391 |
132 | K>N | No |
ClinGen Ensembl |
|
CA380867397 rs1591146252 |
133 | V>G | No |
ClinGen Ensembl |
|
CA380867400 rs1435270808 |
134 | T>P | No |
ClinGen gnomAD |
|
CA380867407 rs766834617 |
135 | K>R | No |
ClinGen ExAC gnomAD |
|
CA6038677 rs766834617 |
135 | K>T | No |
ClinGen ExAC gnomAD |
|
rs1444627315 CA380867417 |
136 | Q>H | No |
ClinGen TOPMed |
|
CA380867415 rs1329297011 |
136 | Q>R | No |
ClinGen TOPMed |
|
CA6038678 CA6038679 rs754318423 |
138 | N>K | No |
ClinGen ExAC TOPMed gnomAD |
|
CA380867431 rs1399468952 |
138 | N>S | No |
ClinGen gnomAD |
|
CA6038680 rs765890483 |
139 | D>E | No |
ClinGen ExAC gnomAD |
|
rs529767500 CA6038681 |
141 | C>* | No |
ClinGen 1000Genomes ExAC TOPMed gnomAD |
|
rs371928542 CA6038682 |
142 | K>E | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
rs780645501 CA6038683 |
143 | H>R | No |
ClinGen ExAC gnomAD |
|
rs755782253 CA6038685 |
145 | L>Q | No |
ClinGen ExAC gnomAD |
|
CA6038686 rs779822359 |
146 | S>T | No |
ClinGen ExAC gnomAD |
|
CA222948321 rs1039192806 |
147 | L>H | No |
ClinGen TOPMed |
|
CA380867502 rs1197593774 |
149 | G>D | No |
ClinGen gnomAD |
|
CA222948322 rs11541090 |
151 | P>L | No |
ClinGen Ensembl |
|
rs1437446180 CA380867544 |
155 | A>V | No |
ClinGen gnomAD |
|
rs768560253 CA6038688 |
156 | P>A | No |
ClinGen ExAC TOPMed gnomAD |
|
rs768560253 CA380867546 |
156 | P>S | No |
ClinGen ExAC TOPMed gnomAD |
|
CA6038689 rs778852873 |
159 | A>T | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen ExAC NCI-TCGA TOPMed gnomAD |
rs1591146303 CA380867607 |
165 | A>T | No |
ClinGen Ensembl |
|
rs760943389 CA6038693 |
169 | A>S | No |
ClinGen ExAC gnomAD |
|
CA6038694 rs771315924 |
171 | K>I | No |
ClinGen ExAC gnomAD |
|
CA380867656 rs1444127309 |
173 | Y>D | No |
ClinGen TOPMed gnomAD |
|
rs532021925 CA6038695 |
175 | A>V | No |
ClinGen 1000Genomes ExAC TOPMed gnomAD |
|
rs765802805 CA6038697 |
176 | A>V | No |
ClinGen ExAC gnomAD |
|
CA380867681 rs1565315707 |
177 | T>A | No |
ClinGen Ensembl |
|
CA6038698 rs552145732 |
177 | T>N | No |
ClinGen 1000Genomes ExAC gnomAD |
|
CA6038699 rs144781972 |
178 | E>K | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
CA380867686 rs144781972 |
178 | E>Q | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
CA380867706 rs1306950248 |
180 | M>I | No |
ClinGen TOPMed |
|
rs1251959751 CA380867701 |
180 | M>V | No |
ClinGen gnomAD |
|
CA380867722 rs1197013504 |
182 | C>F | No |
ClinGen gnomAD |
|
CA6038701 rs749967877 |
184 | T>S | No |
ClinGen ExAC TOPMed gnomAD |
|
CA6038702 rs755763272 |
186 | G>S | No |
ClinGen ExAC gnomAD |
|
CA380867753 rs1265253316 |
187 | S>T | No |
ClinGen gnomAD |
|
CA6038703 rs766070774 |
189 | V>L | No |
ClinGen ExAC gnomAD |
|
rs774159619 CA222948374 |
190 | L>P | No |
ClinGen Ensembl |
|
CA6038704 rs753589075 |
190 | L>V | No |
ClinGen ExAC TOPMed gnomAD |
|
CA380867774 rs754770893 |
191 | M>R | No |
ClinGen ExAC TOPMed gnomAD |
|
CA6038705 rs754770893 |
191 | M>T | No |
ClinGen ExAC TOPMed gnomAD |
|
CA380867780 rs1302549783 |
192 | R>* | No |
ClinGen TOPMed |
|
CA6038706 rs778764875 |
192 | R>Q | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen ExAC NCI-TCGA gnomAD |
rs1591146365 CA380867786 |
193 | H>P | No |
ClinGen Ensembl |
|
CA380867789 rs1394726261 |
193 | H>Q | No |
ClinGen gnomAD |
|
rs1293287618 CA380867804 |
196 | A>T | No |
ClinGen TOPMed gnomAD |
|
rs1565315743 CA380867806 |
196 | A>V | No |
ClinGen Ensembl |
|
CA380867826 rs1419567262 |
199 | A>T | No |
ClinGen TOPMed |
|
CA380867842 rs1381476547 |
201 | K>R | No |
ClinGen TOPMed |
|
TCGA novel | 201 | K>S | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
rs777028114 CA6038712 |
211 | R>Q | No |
ClinGen ExAC gnomAD |
|
CA380867910 rs1216844828 |
211 | R>W | No |
ClinGen gnomAD |
|
rs1421604696 CA380867946 |
214 | Q>H | No |
ClinGen TOPMed |
|
rs1335710891 CA380867940 |
214 | Q>R | No |
ClinGen gnomAD |
|
CA380867951 rs746170099 |
215 | E>* | No |
ClinGen ExAC TOPMed gnomAD |
|
rs746170099 CA6038713 |
215 | E>K | No |
ClinGen ExAC TOPMed gnomAD |
|
rs1565315766 CA380868003 |
219 | N>K | No |
ClinGen Ensembl |
|
rs1418929101 CA380868009 |
220 | Q>R | No |
ClinGen Ensembl |
|
rs770299892 CA6038714 |
225 | D>Y | No |
ClinGen ExAC gnomAD |
|
CA380868084 rs1187059096 |
226 | L>V | No |
ClinGen gnomAD |
|
CA6038715 rs775779348 |
228 | I>L | No |
ClinGen ExAC TOPMed gnomAD |
|
CA6038716 rs775779348 |
228 | I>V | No |
ClinGen ExAC TOPMed gnomAD |
|
CA380868151 rs1565315778 |
232 | S>T | No |
ClinGen Ensembl |
|
rs764549465 CA6038717 |
235 | C>S | No |
ClinGen ExAC gnomAD |
|
rs1426764580 CA380868200 |
236 | E>G | No |
ClinGen Ensembl |
|
rs772757950 CA6038718 |
236 | E>K | No |
ClinGen ExAC gnomAD |
|
CA222948498 rs528371679 |
238 | I>M | No |
ClinGen 1000Genomes ExAC TOPMed gnomAD |
|
rs199499938 CA380868221 |
239 | R>P | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
rs199499938 CA6038720 |
239 | R>Q | Variant assessed as Somatic; 4.62e-05 impact. [NCI-TCGA] | No |
ClinGen ESP ExAC NCI-TCGA TOPMed gnomAD |
CA380868219 rs1460589167 |
239 | R>W | No |
ClinGen TOPMed gnomAD |
|
rs754683010 CA6038722 |
244 | K>R | No |
ClinGen ExAC gnomAD |
|
CA6038726 rs777591250 |
245 | R>L | No |
ClinGen ExAC gnomAD |
|
TCGA novel | 245 | R>Q | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
rs200397900 CA6038724 |
245 | R>W | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
CA380868263 rs1312132270 |
246 | A>T | No |
ClinGen TOPMed |
|
CA380868296 rs1415571176 |
248 | D>E | Variant assessed as Somatic; impact. [NCI-TCGA] | No |
ClinGen NCI-TCGA TOPMed |
TCGA novel | 248 | D>N | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
rs1393063419 CA380868358 |
253 | H>P | No |
ClinGen gnomAD |
|
CA380868373 rs1356098864 |
254 | K>R | No |
ClinGen gnomAD |
|
rs757420433 CA6038728 |
257 | E>* | No |
ClinGen ExAC TOPMed gnomAD |
|
rs1318533237 CA380868426 |
257 | E>D | No |
ClinGen gnomAD |
|
rs757420433 CA222948552 |
257 | E>K | No |
ClinGen ExAC TOPMed gnomAD |
|
rs141868713 CA6038729 |
259 | I>M | No |
ClinGen 1000Genomes ESP ExAC TOPMed gnomAD |
|
rs371695318 CA6038730 |
260 | V>M | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen ESP ExAC NCI-TCGA TOPMed gnomAD |
rs775893236 CA6038732 |
261 | R>Q | No |
ClinGen ExAC TOPMed gnomAD |
|
rs770209728 CA6038731 |
261 | R>W | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen ExAC NCI-TCGA |
rs749666139 CA6038733 |
262 | R>* | No |
ClinGen ExAC gnomAD |
|
CA6038734 rs769159675 |
262 | R>Q | No |
ClinGen ExAC TOPMed gnomAD |
|
CA6038735 rs148519764 |
263 | L>V | No |
ClinGen 1000Genomes ESP ExAC TOPMed gnomAD |
|
CA222948621 rs922082825 |
264 | D>N | No |
ClinGen TOPMed |
|
rs1179788168 CA380868513 |
266 | N>H | No |
ClinGen gnomAD |
|
rs760118285 CA6038736 |
266 | N>S | No |
ClinGen ExAC gnomAD |
|
CA6038737 rs770414602 |
267 | K>Q | No |
ClinGen ExAC gnomAD |
|
CA380868535 rs1160272664 |
268 | Y>D | No |
ClinGen TOPMed gnomAD |
|
CA380868534 rs1160272664 |
268 | Y>H | No |
ClinGen TOPMed gnomAD |
|
CA380868543 rs1488529887 |
269 | P>A | No |
ClinGen TOPMed |
|
CA6038738 rs138109450 |
269 | P>L | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
CA222948639 rs865811809 |
271 | P>S | No |
ClinGen Ensembl |
|
rs1315289001 CA380868569 |
273 | N>S | No |
ClinGen gnomAD |
|
CA6038739 rs759153619 |
274 | W>* | No |
ClinGen ExAC TOPMed gnomAD |
|
rs1447331543 CA380868583 |
275 | L>F | No |
ClinGen gnomAD |
|
CA222948658 rs748969364 |
276 | H>Y | No |
ClinGen TOPMed |
|
rs752485852 CA6038741 |
277 | K>E | No |
ClinGen ExAC gnomAD |
|
CA6038744 rs557497901 |
280 | H>Q | No |
ClinGen 1000Genomes ExAC gnomAD |
|
rs764028854 CA6038743 |
280 | H>Y | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen ExAC NCI-TCGA TOPMed gnomAD |
rs1236422237 CA380868622 |
281 | Q>E | No |
ClinGen gnomAD |
|
rs1233981826 CA380868631 |
282 | L>F | No |
ClinGen TOPMed |
|
CA380868646 rs1276617464 |
284 | L>S | No |
ClinGen TOPMed |
|
rs750436847 CA222948680 |
286 | P>A | No |
ClinGen TOPMed gnomAD |
|
TCGA novel | 286 | P>H | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
CA6038747 rs757326491 |
286 | P>R | No |
ClinGen ExAC gnomAD |
|
rs1234311718 CA380868667 |
287 | E>V | No |
ClinGen gnomAD |
|
rs781421590 CA6038748 |
288 | V>A | No |
ClinGen ExAC gnomAD |
|
CA222948700 rs369023056 |
288 | V>M | No |
ClinGen ESP TOPMed |
|
CA380868676 rs1385555128 |
289 | L>Q | No |
ClinGen TOPMed |
|
rs186164169 CA6038749 |
290 | D>V | No |
ClinGen 1000Genomes ExAC gnomAD |
|
rs1173228789 CA380868696 |
292 | E>V | No |
ClinGen TOPMed |
|
CA380868715 rs1210118162 |
295 | E>A | No |
ClinGen gnomAD |
|
rs780164160 CA6038751 |
297 | K>N | No |
ClinGen ExAC gnomAD |
|
rs749625547 CA6038752 |
299 | S>N | No |
ClinGen ExAC TOPMed gnomAD |
|
CA6038753 rs188983237 |
300 | E>K | No |
ClinGen 1000Genomes ExAC TOPMed gnomAD |
|
CA6038754 rs188983237 |
300 | E>Q | No |
ClinGen 1000Genomes ExAC TOPMed gnomAD |
|
rs1174021019 CA380868758 |
301 | P>R | No |
ClinGen gnomAD |
|
TCGA novel | 302 | N>S | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
CA380868793 rs748648821 |
306 | L>V | No |
ClinGen ExAC TOPMed gnomAD |
|
CA6038756 rs772603170 |
307 | I>M | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen ExAC NCI-TCGA gnomAD |
rs1304135383 CA380868817 |
309 | F>L | No |
ClinGen gnomAD |
|
CA6038758 rs759067341 |
309 | F>V | No |
ClinGen ExAC gnomAD |
|
rs1344202031 CA380868827 |
311 | C>S | No |
ClinGen gnomAD |
|
rs769444109 CA6038759 |
314 | K>E | No |
ClinGen ExAC gnomAD |
|
rs199498803 CA6038760 |
316 | F>Y | No |
ClinGen 1000Genomes ExAC TOPMed gnomAD |
|
CA380868875 rs1268047337 |
317 | S>C | No |
ClinGen TOPMed |
|
rs762754689 CA6038761 |
318 | E>Q | No |
ClinGen ExAC gnomAD |
|
rs751470906 COSM929521 CA6038764 |
320 | R>* | Variant assessed as Somatic; 0.0 impact. endometrium [NCI-TCGA, Cosmic] | No |
ClinGen cosmic curated ExAC NCI-TCGA gnomAD |
CA380868893 rs1565315915 |
320 | R>Q | Variant assessed as Somatic; impact. [NCI-TCGA] | No |
ClinGen Ensembl NCI-TCGA |
rs765400166 CA222948753 |
321 | I>M | No |
ClinGen TOPMed |
|
CA6038765 rs141650861 |
321 | I>T | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
rs202130520 CA6038766 |
322 | R>C | No |
ClinGen ExAC TOPMed gnomAD |
|
rs756180049 CA6038767 |
322 | R>H | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen ExAC NCI-TCGA TOPMed gnomAD |
CA380868917 rs1340359623 |
324 | G>V | No |
ClinGen TOPMed |
|
CA6038769 rs780263785 |
325 | V>A | No |
ClinGen ExAC gnomAD |
|
rs1272223084 CA380868934 |
327 | R>K | No |
ClinGen TOPMed |
|
TCGA novel | 329 | S>N | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
TCGA novel | 330 | K>N | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
rs753991316 CA6038770 |
331 | S>T | No |
ClinGen ExAC gnomAD |
|
rs755294689 CA6038771 |
332 | R>C | No |
ClinGen ExAC gnomAD |
|
CA6038772 rs371918257 |
332 | R>H | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
CA6038773 rs371918257 |
332 | R>L | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
rs1398351987 CA380868978 |
334 | G>S | No |
ClinGen gnomAD |
|
rs772515013 CA6038774 |
336 | T>A | No |
ClinGen ExAC gnomAD |
|
CA380869002 rs1179700751 |
337 | Q>H | No |
ClinGen gnomAD |
|
CA222948798 rs1013335904 |
337 | Q>K | Variant assessed as Somatic; impact. [NCI-TCGA] | No |
ClinGen NCI-TCGA TOPMed |
CA6038775 rs758718503 |
339 | R>C | No |
ClinGen ExAC TOPMed gnomAD |
|
COSM1355266 rs573495657 CA6038776 |
339 | R>H | Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] | No |
ClinGen cosmic curated 1000Genomes ExAC NCI-TCGA gnomAD |
CA380869023 rs1410121025 |
341 | D>G | No |
ClinGen TOPMed |
|
rs1271811640 CA380869031 |
342 | D>G | No |
ClinGen gnomAD |
|
rs1355597557 CA380869056 |
345 | K>R | No |
ClinGen TOPMed |
|
rs1255810639 CA380869062 |
346 | V>A | No |
ClinGen gnomAD |
|
CA6038777 rs542490356 |
346 | V>M | No |
ClinGen 1000Genomes ExAC gnomAD |
|
TCGA novel | 348 | G>D | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
rs150508629 CA6038779 |
348 | G>S | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
CA6038780 rs768399301 |
349 | S>L | No |
ClinGen ExAC gnomAD |
|
rs774266785 CA6038781 |
351 | S>F | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen ExAC NCI-TCGA gnomAD |
rs1437773582 CA380869099 |
353 | A>P | No |
ClinGen TOPMed |
|
rs1193025547 CA380869113 |
355 | R>C | No |
ClinGen gnomAD |
|
rs761723999 CA6038782 |
355 | R>H | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen ExAC NCI-TCGA TOPMed gnomAD |
CA6038783 rs767523831 |
356 | K>Q | No |
ClinGen ExAC gnomAD |
|
TCGA novel | 356 | K>Q | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
rs773287912 CA6038784 |
356 | K>R | No |
ClinGen ExAC gnomAD |
|
rs1803573 CA222948884 |
357 | E>D | No |
ClinGen Ensembl |
|
TCGA novel | 357 | E>V | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
rs370181656 CA6038785 |
358 | P>T | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
rs1320250237 CA380869145 |
360 | P>S | No |
ClinGen gnomAD |
|
CA6038787 rs753989476 |
362 | G>R | No |
ClinGen ExAC gnomAD |
|
rs138459213 CA6038788 |
364 | T>I | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
rs765464647 CA6038790 |
368 | A>T | No |
ClinGen ExAC TOPMed gnomAD |
|
CA380869231 rs1283187869 |
373 | A>T | No |
ClinGen gnomAD |
|
rs7931165 CA222948912 |
376 | F>L | No |
ClinGen Ensembl |
|
CA380869281 rs1356130035 |
380 | K>R | No |
ClinGen gnomAD |
No associated diseases with P39748
5 regional properties for P39748
Type | Name | Position | InterPro Accession |
---|---|---|---|
domain | XPG, N-terminal | 1 - 107 | IPR006085 |
domain | XPG-I domain | 146 - 233 | IPR006086 |
conserved_site | Helix-hairpin-helix motif, class 2 | 220 - 253 | IPR008918 |
conserved_site | XPG conserved site | 79 - 93 | IPR019974-1 |
conserved_site | XPG conserved site | 149 - 163 | IPR019974-2 |
Functions
7 GO annotations of cellular component
Name | Definition |
---|---|
chromosome, telomeric region | The end of a linear chromosome, required for the integrity and maintenance of the end. A chromosome telomere usually includes a region of telomerase-encoded repeats the length of which rarely exceeds 20 bp each and that permits the formation of a telomeric loop (T-loop). The telomeric repeat region is usually preceded by a sub-telomeric region that is gene-poor but rich in repetitive elements. Some telomeres only consist of the latter part (for eg. D. melanogaster telomeres). |
membrane | A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it. |
mitochondrion | A semiautonomous, self replicating organelle that occurs in varying numbers, shapes, and sizes in the cytoplasm of virtually all eukaryotic cells. It is notably the site of tissue respiration. |
nucleolus | A small, dense body one or more of which are present in the nucleus of eukaryotic cells. It is rich in RNA and protein, is not bounded by a limiting membrane, and is not seen during mitosis. Its prime function is the transcription of the nucleolar DNA into 45S ribosomal-precursor RNA, the processing of this RNA into 5.8S, 18S, and 28S components of ribosomal RNA, and the association of these components with 5S RNA and proteins synthesized outside the nucleolus. This association results in the formation of ribonucleoprotein precursors; these pass into the cytoplasm and mature into the 40S and 60S subunits of the ribosome. |
nucleoplasm | That part of the nuclear content other than the chromosomes or the nucleolus. |
nucleus | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |
protein-containing complex | A stable assembly of two or more macromolecules, i.e. proteins, nucleic acids, carbohydrates or lipids, in which at least one component is a protein and the constituent parts function together. |
12 GO annotations of molecular function
Name | Definition |
---|---|
5'-3' exonuclease activity | Catalysis of the hydrolysis of ester linkages within nucleic acids by removing nucleotide residues from the 5' end. |
5'-flap endonuclease activity | Catalysis of the cleavage of a 5' flap structure in DNA, but not other DNA structures; processes the 5' ends of Okazaki fragments in lagging strand DNA synthesis. |
damaged DNA binding | Binding to damaged DNA. |
DNA binding | Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid). |
double-stranded DNA binding | Binding to double-stranded DNA. |
double-stranded DNA exodeoxyribonuclease activity | Catalysis of the sequential cleavage of mononucleotides from a free 5' or 3' terminus of a double-stranded DNA molecule. |
endonuclease activity | Catalysis of the hydrolysis of ester linkages within nucleic acids by creating internal breaks. |
exonuclease activity | Catalysis of the hydrolysis of ester linkages within nucleic acids by removing nucleotide residues from the 3' or 5' end. |
flap endonuclease activity | Catalysis of the cleavage of a flap structure in DNA, but not other DNA structures; processes the ends of Okazaki fragments in lagging strand DNA synthesis. |
magnesium ion binding | Binding to a magnesium (Mg) ion. |
manganese ion binding | Binding to a manganese ion (Mn). |
RNA-DNA hybrid ribonuclease activity | Catalysis of the endonucleolytic cleavage of RNA in RNA-DNA hybrids to 5'-phosphomonoesters. |
11 GO annotations of biological process
Name | Definition |
---|---|
base-excision repair, gap-filling | Repair of the damaged strand by the combined action of an apurinic endouclease that degrades a few bases on the damaged strand and a polymerase that synthesizes a 'patch' in the 5' to 3' direction, using the undamaged strand as a template. |
DNA repair | The process of restoring DNA after damage. Genomes are subject to damage by chemical and physical agents in the environment (e.g. UV and ionizing radiations, chemical mutagens, fungal and bacterial toxins, etc.) and by free radicals or alkylating agents endogenously generated in metabolism. DNA is also damaged because of errors during its replication. A variety of different DNA repair pathways have been reported that include direct reversal, base excision repair, nucleotide excision repair, photoreactivation, bypass, double-strand break repair pathway, and mismatch repair pathway. |
DNA replication | The cellular metabolic process in which a cell duplicates one or more molecules of DNA. DNA replication begins when specific sequences, known as origins of replication, are recognized and bound by initiation proteins, and ends when the original DNA molecule has been completely duplicated and the copies topologically separated. The unit of replication usually corresponds to the genome of the cell, an organelle, or a virus. The template for replication can either be an existing DNA molecule or RNA. |
DNA replication, removal of RNA primer | Removal of the Okazaki RNA primer from the lagging strand of replicating DNA, by a combination of the actions of DNA polymerase, DNA helicase and an endonuclease. |
double-strand break repair | The repair of double-strand breaks in DNA via homologous and nonhomologous mechanisms to reform a continuous DNA helix. |
double-strand break repair via homologous recombination | The error-free repair of a double-strand break in DNA in which the broken DNA molecule is repaired using homologous sequences. A strand in the broken DNA searches for a homologous region in an intact chromosome to serve as the template for DNA synthesis. The restoration of two intact DNA molecules results in the exchange, reciprocal or nonreciprocal, of genetic material between the intact DNA molecule and the broken DNA molecule. |
memory | The activities involved in the mental information processing system that receives (registers), modifies, stores, and retrieves informational stimuli. The main stages involved in the formation and retrieval of memory are encoding (processing of received information by acquisition), storage (building a permanent record of received information as a result of consolidation) and retrieval (calling back the stored information and use it in a suitable way to execute a given task). |
nucleic acid phosphodiester bond hydrolysis | The nucleic acid metabolic process in which the phosphodiester bonds between nucleotides are cleaved by hydrolysis. |
positive regulation of sister chromatid cohesion | Any process that activates or increases the frequency, rate or extent of sister chromatid cohesion. |
telomere maintenance via semi-conservative replication | The process in which telomeric DNA is synthesized semi-conservatively by the conventional replication machinery and telomeric accessory factors as part of cell cycle DNA replication. |
UV protection | Any process in which an organism or cell protects itself from ultraviolet radiation (UV), which may also result in resistance to repeated exposure to UV. |
9 homologous proteins in AiPD
UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
---|---|---|---|---|
Q58DH8 | FEN1 | Flap endonuclease 1 | Bos taurus (Bovine) | PR |
Q5ZLN4 | FEN1 | Flap endonuclease 1 | Gallus gallus (Chicken) | PR |
Q9VRJ0 | Gen | Flap endonuclease GEN | Drosophila melanogaster (Fruit fly) | PR |
Q9UQ84 | EXO1 | Exonuclease 1 | Homo sapiens (Human) | EV |
Q5XIP6 | Fen1 | Flap endonuclease 1 | Rattus norvegicus (Rat) | PR |
Q75LI2 | FEN1B | Flap endonuclease 1-B | Oryza sativa subsp japonica (Rice) | PR |
Q9SXQ6 | FEN1A | Flap endonuclease 1-A | Oryza sativa subsp japonica (Rice) | PR |
C5YUK3 | FEN1-A | Flap endonuclease 1-A | Sorghum bicolor (Sorghum) (Sorghum vulgare) | PR |
Q9M2Z3 | SEND1 | Single-strand DNA endonuclease 1 | Arabidopsis thaliana (Mouse-ear cress) | PR |
10 | 20 | 30 | 40 | 50 | 60 |
MGIQGLAKLI | ADVAPSAIRE | NDIKSYFGRK | VAIDASMSIY | QFLIAVRQGG | DVLQNEEGET |
70 | 80 | 90 | 100 | 110 | 120 |
TSHLMGMFYR | TIRMMENGIK | PVYVFDGKPP | QLKSGELAKR | SERRAEAEKQ | LQQAQAAGAE |
130 | 140 | 150 | 160 | 170 | 180 |
QEVEKFTKRL | VKVTKQHNDE | CKHLLSLMGI | PYLDAPSEAE | ASCAALVKAG | KVYAAATEDM |
190 | 200 | 210 | 220 | 230 | 240 |
DCLTFGSPVL | MRHLTASEAK | KLPIQEFHLS | RILQELGLNQ | EQFVDLCILL | GSDYCESIRG |
250 | 260 | 270 | 280 | 290 | 300 |
IGPKRAVDLI | QKHKSIEEIV | RRLDPNKYPV | PENWLHKEAH | QLFLEPEVLD | PESVELKWSE |
310 | 320 | 330 | 340 | 350 | 360 |
PNEEELIKFM | CGEKQFSEER | IRSGVKRLSK | SRQGSTQGRL | DDFFKVTGSL | SSAKRKEPEP |
370 | |||||
KGSTKKKAKT | GAAGKFKRGK |